发明名称 IMIDAZOPYRIMIDINE AND IMIDAZOTRIAZINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
摘要 The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same:;wherein X, Z, R1 and R2 are as defined in the specification.;The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.
申请公布号 US2016251361(A1) 申请公布日期 2016.09.01
申请号 US201615053569 申请日期 2016.02.25
申请人 SK BIOPHARMACEUTICALS CO., LTD. 发明人 PARK Chun Eung;JANG Young Koo;SHIN Yong Je;KIM Ji Yeon;HAM Seung Mo;KIM Yong Gil;MIN Hye Kyung;CHA Soo Bong;JUNG Hyo Jun;LEE Ju Young;HAN Seung Nam;CHUNG Jin Yong;CHOI Eun Ju;JOUNG Chan Mi;PARK Jong Sil;LEE Ji Won;CHO Nahm Ryune;RYU Eun Ju;MAENG Cheol Young
分类号 C07D487/04 主分类号 C07D487/04
代理机构 代理人
主权项 1. A compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof: wherein X is CH or N;Z is O or S;R1 is aryl optionally substituted with one or more substituents selected from halo, hydroxy, alkyl, alkoxy, alkylthio, amino, dialkylamino, cyano, formyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, carbamoyloxy alkyl, alkyl-C(O)O-alkyl, dialkylaminoalkyl and 5- or 6-membered heterocycloalkylalkyl; or 5- to 12-membered, unsaturated heterocyclyl optionally substituted with one or more substituents selected from halo, hydroxy, alkyl, alkoxy and haloalkyl; andR2 is aryl optionally substituted with one or more substituents selected from halo, deuterium, hydroxy and alkyl; or 5- to 12-membered, unsaturated heterocyclyl optionally substituted with one or more substituents selected from halo and alkyl.
地址 Seoul KR